Primary Recipient

TARGETED THERAPY TECHNOLOGIES, LLC

Amount

$2,769,464.00

Award Date

9/27/2010

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

Retinoblastoma is a rare intraocular cancer in children currently treated either by removing the eye or giving the child systemic chemotherapy with its attendant toxicity and marginal efficacy for sustained intraocular remission. The episcleral device (a